Transforming Clinical Data Management with Clinical Data and Analytics Platforms

Life Sciences, Clinical Trials, Pharmaceutical Regulation, Pharmaceutical, Commercialization & HEOR,
  • Monday, October 21, 2024 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
  • 60 min

The clinical development landscape has become increasingly complex, evolving rapidly in response to post-pandemic demands, hybrid trial designs and the growing use of real-world data (RWD). These changes are driving the need for sponsors to conduct faster, more efficient trials while managing a rising volume of clinical data.

Adding to this complexity, ongoing trials across multiple therapy areas, many of which are outsourced to contract research organizations (CROs) can lead to sponsors having lower visibility over trial performance and progress. As regulatory expectations continue to evolve, particularly with the US Food and Drug Administration (FDA)’s review of International Council for Harmonisation (ICH) E6 (R3) guidelines, sponsors are under increased pressure to maintain oversight and ensure the quality, safety and integrity of their trials.

In this webinar, Wendy Morahan, Senior Director of Clinical Data Analytics at IQVIA Technologies, along with an Everest Group Industry Analyst, will dive into the pressing challenges sponsors face in clinical data management today. They will explore how an end-to-end unified clinical data and analytics (D&A) platform can offer a solution to sponsor challenges by acting as a single source of truth, offering a centralized hub to manage all aspects of their clinical trials in real time.

This webinar will also provide an opportunity for clinical trial stakeholders, including biopharma companies, MedTech enterprises and CROs to learn how they can harness the power of a unified D&A platform to navigate the complexities of modern clinical trials. The speakers will also delve into practical aspects that sponsors consider when deciding whether to deploy a clinical D&A platform, like evaluating return on investment (ROI) and key performance indicators (KPIs) to measure success.

They will also explore the role of next-gen technologies such as artificial intelligence (AI) and generative AI and how they are leveraged by these platforms to automate repetitive tasks and extract valuable insights for clinical trials.

Register for this webinar today to discover how clinical data management can be optimized to help sponsors navigate the complexities of modern clinical trials, improve oversight and ensure data quality.

Speakers

Wendy Morahan, Senior Director, Clinical Data Analytic Solutions, IQVIA Technologies

Wendy has 25+ years experience in the life sciences industry with a career spanning academic research, preclinical drug discovery, and clinical trials, culminating in a focus and passion for delivering technology solutions that help bring treatments to patients faster.  Wendy is currently part of the product strategy leadership team for IQVIA Clinical Data Analytics Suite (CDAS), providing both SaaS solutions for the market as well as IQVIA’s internal CRO needs.  As part of the CDAS team, Wendy is responsible for strategy, product management leadership, and Go to Market activities.

Message Presenter
Nisarg Shah, Everest Group

Nisarg Shah, Practice Director, Everest Group

Nisarg Shah is a Practice Director with the healthcare and life sciences team and manages Everest Group’s Clinical Development Technology outsourcing offerings. He focuses on advisory across the clinical development value chain.

Leveraging his significant consulting and research experience, he has advised many global service providers, product vendors and enterprises on digital transformation, product strategy and go-to-market strategy. He also has significant experience advising clients on mergers and acquisitions, competitor assessment and vendor assessment engagements.

He has authored industry reports on clinical development, decentralized clinical trials and D&A platforms and drives thought leadership pieces across the clinical technology space for the firm.

Message Presenter

Who Should Attend?

This webinar will appeal to CEOs, CMOs (medical), SVPs, VPs, AVPs, Sr. Directors, Directors and Associate Directors from emerging biopharma (EBP)/small and mid pharma as well as large pharma with functional roles in:

  • Clinical operations
  • Biostatistics
  • Clinical Innovation/Data Science/AI Executives
  • Medical affairs
  • Safety
  • Market access

What You Will Learn

Attendees will learn about:

  • Current business challenges that sponsors face in clinical data management and the impact of these challenges on trial timelines, regulatory compliance, decision-making and overall trial efficiency and performance
  • The potential of an end-to-end unified clinical D&A platform in addressing these challenges by enabling real-time data access, improving data quality, automating the data cleaning and generating actionable insights to streamline trial oversight
  • Implementation considerations for sponsors when deploying a clinical D&A platform such as evaluating ROI and KPIs to determine the platform’s success

Xtalks Partner

IQVIA 

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account